| Bioactivity | Muvalaplin (LY3473329) is an orally active reagent of lipoprotein (a) (Lp (a)). At present, research on Muvalaplin oral reagent is ongoing[1]. |
| Target | Lipoprotein(a) (Lp(a)) |
| Name | Muvalaplin |
| CAS | 2565656-70-2 |
| Formula | C42H54N4O6 |
| Molar Mass | 710.90 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Bhatia HS, et al. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies. J Clin Med. 2022 Oct 13;11(20):6040. |
Muvalaplin
CAS: 2565656-70-2 F: C42H54N4O6 W: 710.90
Muvalaplin (LY3473329) is an orally active reagent of lipoprotein (a) (Lp (a)). At present, research on Muvalaplin oral
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.